Skip to content
The Longevity Archive
MOTS-c in all countries

Legal status · United States

Is MOTS-c legal in the United States?

Not approvedLongevityEvidence: Preliminary

No. MOTS-c is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Preliminary.

MOTS-c in the United States at a glance

ClassificationNot approved; research use only
FDA approval statusNot FDA-approved. PCAC voted 7 to 5 to recommend for compounding (July 2026); awaiting FDA rulemaking; one Phase 2a trial recruiting
Evidence levelPreliminary (research strength: Preliminary)
ReviewedSep 2026

Classification and note come from the MOTS-c profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.

What this means

  • 01

    No product containing MOTS-c is approved by FDA for any use in the United States, so nothing on the market is authorized for people.

  • 02

    "Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.

  • 03

    Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.

What MOTS-c is

A mitochondrial-derived peptide studied as an exercise mimetic that improves metabolic homeostasis and insulin sensitivity in animal models.

MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA that acts as a signaling molecule regulating metabolism. In animal studies it improves insulin sensitivity, protects against diet-induced obesity, and mimics some effects of exercise; early human data are limited.

Mechanism: Translocates to the nucleus under metabolic stress and activates AMPK-related pathways that regulate glucose and lipid metabolism.

Regulatory history: Not FDA-approved. PCAC voted 7 to 5 to recommend for compounding (July 2026); awaiting FDA rulemaking; one Phase 2a trial recruiting

How FDA treats this kind of product

Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.

The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for MOTS-c at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

MOTS-c in other countries

Frequently asked questions

Is MOTS-c legal in the United States?

No. MOTS-c is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Preliminary.

Can I buy MOTS-c in the United States?

No approved product exists to buy. In the United States MOTS-c is classified as "Not approved; research use only", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.

Is MOTS-c FDA approved?

No. FDA status: Not FDA-approved. PCAC voted 7 to 5 to recommend for compounding (July 2026); awaiting FDA rulemaking; one Phase 2a trial recruiting. Current US classification: "Not approved; research use only". Evidence level: Preliminary.

Related compounds in the United States

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for MOTS-c live on its compound profile.

MOTS-c profile

This page is general information about the regulatory status of MOTS-c in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.